vantocil has been researched along with Encephalitis Infection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ghoshal, U; Kalra, SK; Sharma, G; Tejan, N | 1 |
| Aqeel, Y; Khan, NA; Siddiqui, R | 1 |
2 review(s) available for vantocil and Encephalitis Infection
| Article | Year |
|---|---|
Nanoparticles based therapeutic efficacy against Acanthamoeba: Updates and future prospect.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Amebiasis; Amebicides; Biguanides; Central Nervous System Protozoal Infections; Chlorhexidine; Drug Delivery Systems; Immunocompetence; Immunocompromised Host; Infectious Encephalitis; Nanoparticles; Trophozoites | 2020 |
The Development of Drugs against Acanthamoeba Infections.
Topics: Acanthamoeba; Acanthamoeba Keratitis; Amphotericin B; Animals; Antiprotozoal Agents; Azoles; Biguanides; Caspofungin; Cefazolin; Chlorhexidine; Echinocandins; Humans; Infectious Encephalitis; Lipopeptides; Meropenem; Natamycin; Polymyxin B; Thienamycins | 2016 |